Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.

310 E 67th St, Suite 1-12‎, New York, NY 10065
(646) 856-9261
[email protected]

Corey Sohmer, M.B.A.

VP of Finance & Accounting

Corey brings to Rgenix more than 25 years of progressive leadership experience in finance and accounting, including approximately 15 years in small to medium size publicly traded biotechnology companies. He is responsible for the accounting and finance functions of the company. His past experience includes building out financial infrastructures, accounting, capital raises, operations and Sarbanes-Oxley implementation.

Prior to joining Rgenix, he was the VP of Finance and Business Development at Actinium Pharmaceuticals, Director of Corporate Finance at Cyclacel Pharmaceuticals, and Senior Director of Financial Planning and External Reporting at EpiCept Corporation.  Corey has an M.B.A. and a Bachelor of Science from Bentley University and is licensed as a C.P.A. (inactive) in the State of New Jersey.